Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Evaluation of the Non-HDL Cholesterol to Apolipoprotein B Ratio as a Screening Test for Dysbetalipoproteinemia.

Boot CS, Middling E, Allen J, Neely RDG.

Clin Chem. 2019 Feb;65(2):313-320. doi: 10.1373/clinchem.2018.292425. Epub 2018 Dec 11.

PMID:
30538126
2.

Hepatitis C virus and atherosclerosis: A legacy after virologic cure?

Bassendine MF, Nielsen SU, Bridge SH, Felmlee DJ, Sheridan DA, Packard CJ, Neely RD.

Clin Res Hepatol Gastroenterol. 2017 Feb;41(1):25-30. doi: 10.1016/j.clinre.2016.09.008. Epub 2016 Nov 11. Review.

PMID:
27840032
3.

Study to Improve Cardiovascular Outcomes in high-risk older patieNts (ICON1) with acute coronary syndrome: study design and protocol of a prospective observational study.

Kunadian V, Neely RD, Sinclair H, Batty JA, Veerasamy M, Ford GA, Qiu W.

BMJ Open. 2016 Aug 23;6(8):e012091. doi: 10.1136/bmjopen-2016-012091.

4.

Erratum to: PCSK9 inhibitors in the prevention of cardiovascular disease.

Latimer J, Batty JA, Neely RD, Kunadian V.

J Thromb Thrombolysis. 2016 Oct;42(3):420. No abstract available.

PMID:
27170165
5.

PCSK9 inhibitors in the prevention of cardiovascular disease.

Latimer J, Batty JA, Neely RD, Kunadian V.

J Thromb Thrombolysis. 2016 Oct;42(3):405-19. doi: 10.1007/s11239-016-1364-1. Review. Erratum in: J Thromb Thrombolysis. 2016 Oct;42(3):420.

6.

Phaeochromocytoma and ACTH-dependent cushing's syndrome: tumour crf secretion can mimic pituitary cushing's disease.

Lois KB, Santhakumar A, Vaikkakara S, Mathew S, Long A, Johnson SJ, Peaston R, Neely RDG, Richardson DL, Graham J, Lennard TWJ, Bliss R, Miller M, Ball SG, Pearce SHS, Woods DR, Quinton R.

Clin Endocrinol (Oxf). 2016 Feb;84(2):177-184. doi: 10.1111/cen.12960. Epub 2015 Nov 20.

PMID:
26433209
7.

PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: evidence for genotype-specific regulation of lipoprotein metabolism.

Bridge SH, Sheridan DA, Felmlee DJ, Crossey MM, Fenwick FI, Lanyon CV, Dubuc G, Seidah NG, Davignon J, Thomas HC, Taylor-Robinson SD, Toms GL, Neely RD, Bassendine MF.

J Hepatol. 2015 Apr;62(4):763-70. doi: 10.1016/j.jhep.2014.11.016. Epub 2014 Nov 21.

PMID:
25463543
8.

Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency.

Sheridan DA, Bridge SH, Crossey MM, Felmlee DJ, Thomas HC, Neely RD, Taylor-Robinson SD, Bassendine MF.

Metab Brain Dis. 2014 Sep;29(3):625-34. doi: 10.1007/s11011-014-9520-9. Epub 2014 Mar 12.

PMID:
24615429
9.

A 12-cm mass with no symptoms and unremarkable laboratory results.

Davison AS, Pattman SJ, Neely RD, Bliss R, Ball SG.

Clin Chem. 2013 Nov;59(11):1561-4. doi: 10.1373/clinchem.2013.204438. No abstract available.

10.

Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trial.

Sheridan DA, Bridge SH, Crossey MM, Felmlee DJ, Fenwick FI, Thomas HC, Neely RD, Taylor-Robinson SD, Bassendine MF.

Liver Int. 2014 May;34(5):737-47. doi: 10.1111/liv.12316. Epub 2013 Oct 14.

PMID:
24118830
11.

Lipids and HCV.

Bassendine MF, Sheridan DA, Bridge SH, Felmlee DJ, Neely RD.

Semin Immunopathol. 2013 Jan;35(1):87-100. doi: 10.1007/s00281-012-0356-2. Epub 2012 Oct 31. Review.

PMID:
23111699
12.

Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs).

Sheridan DA, Neely RD, Bassendine MF.

Clin Res Hepatol Gastroenterol. 2013 Feb;37(1):10-6. doi: 10.1016/j.clinre.2012.07.002. Epub 2012 Sep 5. Review.

PMID:
22959093
13.

Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: evidence for an association with interferon sensitivity.

Sheridan DA, Bridge SH, Felmlee DJ, Crossey MM, Thomas HC, Taylor-Robinson SD, Toms GL, Neely RD, Bassendine MF.

J Hepatol. 2012 Jul;57(1):32-8. doi: 10.1016/j.jhep.2012.02.017. Epub 2012 Mar 10.

PMID:
22414761
14.

HCV and the hepatic lipid pathway as a potential treatment target.

Bassendine MF, Sheridan DA, Felmlee DJ, Bridge SH, Toms GL, Neely RD.

J Hepatol. 2011 Dec;55(6):1428-40. doi: 10.1016/j.jhep.2011.06.004. Epub 2011 Jun 28. Review.

15.

Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection.

Bridge SH, Sheridan DA, Felmlee DJ, Nielsen SU, Thomas HC, Taylor-Robinson SD, Neely RD, Toms GL, Bassendine MF.

Gut. 2011 May;60(5):680-7. doi: 10.1136/gut.2010.222133. Epub 2010 Oct 12.

PMID:
20940286
16.

Intravascular transfer contributes to postprandial increase in numbers of very-low-density hepatitis C virus particles.

Felmlee DJ, Sheridan DA, Bridge SH, Nielsen SU, Milne RW, Packard CJ, Caslake MJ, McLauchlan J, Toms GL, Neely RD, Bassendine MF.

Gastroenterology. 2010 Nov;139(5):1774-83, 1783.e1-6. doi: 10.1053/j.gastro.2010.07.047. Epub 2010 Aug 2.

PMID:
20682323
17.

Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project.

Taylor A, Wang D, Patel K, Whittall R, Wood G, Farrer M, Neely RD, Fairgrieve S, Nair D, Barbir M, Jones JL, Egan S, Everdale R, Lolin Y, Hughes E, Cooper JA, Hadfield SG, Norbury G, Humphries SE.

Clin Genet. 2010 Jun;77(6):572-80. doi: 10.1111/j.1399-0004.2009.01356.x. Epub 2010 Mar 13.

PMID:
20236128
18.

Antisense technology to lower LDL cholesterol.

Neely RD, Bassendine MF.

Lancet. 2010 Mar 20;375(9719):959-61. doi: 10.1016/S0140-6736(10)60364-9. No abstract available.

PMID:
20227757
19.

Friedewald equation underestimates low-density lipoprotein cholesterol at low concentrations in young people with and without Type 1 diabetes.

Sibal L, Neely RD, Jones A, Home PD.

Diabet Med. 2010 Jan;27(1):37-45. doi: 10.1111/j.1464-5491.2009.02888.x.

PMID:
20121887
20.

Healthy individuals carrying the PCSK9 p.R46L variant and familial hypercholesterolemia patients carrying PCSK9 p.D374Y exhibit lower plasma concentrations of PCSK9.

Humphries SE, Neely RD, Whittall RA, Troutt JS, Konrad RJ, Scartezini M, Li KW, Cooper JA, Acharya J, Neil A.

Clin Chem. 2009 Dec;55(12):2153-61. doi: 10.1373/clinchem.2009.129759. Epub 2009 Oct 1.

21.

Lipid external quality assessment: commutability between external quality assessment and clinical specimens.

Cramb R, French J, Mackness M, Neely RD, Caslake M, MacKenzie F.

Ann Clin Biochem. 2008 May;45(Pt 3):260-5. doi: 10.1258/acb.2007.007120.

PMID:
18482913
22.

Who needs a lipid clinic?

Neely RD.

Int J Clin Pract. 2008 Jun;62(6):847-9. doi: 10.1111/j.1742-1241.2008.01723.x. No abstract available.

PMID:
18479276
23.

Olanzapine-induced chylomicronemia presenting as acute pancreatitis.

Rossor AM, Leech N, Neely RD.

J Clin Psychopharmacol. 2007 Aug;27(4):395-6. No abstract available.

PMID:
17632226
24.

Provision of laboratory services for lipid analysis in the United Kingdom.

Hutchesson AC, O'Kane MJ, Neely RD, Oleesky DA.

Ann Clin Biochem. 2007 May;44(Pt 3):273-80.

PMID:
17456295
25.

Hepatic surgery-related hypophosphatemia.

Datta HK, Malik M, Neely RD.

Clin Chim Acta. 2007 May 1;380(1-2):13-23. Epub 2007 Feb 2. Review.

PMID:
17349987
26.

Complete reversal of adult-onset isolated hypogonadotropic hypogonadism with clomiphene citrate.

Ioannidou-Kadis S, Wright PJ, Neely RD, Quinton R.

Fertil Steril. 2006 Nov;86(5):1513.e5-9.

PMID:
17070201
27.

Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate.

Graham CA, McIlhatton BP, Kirk CW, Beattie ED, Lyttle K, Hart P, Neely RD, Young IS, Nicholls DP.

Atherosclerosis. 2005 Oct;182(2):331-40.

PMID:
16159606
28.

Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes.

Ravikumar B, Carey PE, Snaar JE, Deelchand DK, Cook DB, Neely RD, English PT, Firbank MJ, Morris PG, Taylor R.

Am J Physiol Endocrinol Metab. 2005 Apr;288(4):E789-97. Epub 2004 Nov 30.

29.

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study.

Freeman DJ, Norrie J, Sattar N, Neely RD, Cobbe SM, Ford I, Isles C, Lorimer AR, Macfarlane PW, McKillop JH, Packard CJ, Shepherd J, Gaw A.

Circulation. 2001 Jan 23;103(3):357-62.

PMID:
11157685
30.

Failure of complete suppression of endogenous glucose production by euglycaemic hyperinsulinaemia in normal humans.

Neely RD, Harper R, Rooney DP, Ennis CN, Bell PM, Trimble ER.

Eur J Clin Invest. 1995 Jun;25(6):447-53.

PMID:
7656925
31.

The effect of cortisol on glucose/glucose-6-phosphate cycle activity and insulin action.

Rooney DP, Neely RD, Cullen C, Ennis CN, Sheridan B, Atkinson AB, Trimble ER, Bell PM.

J Clin Endocrinol Metab. 1993 Nov;77(5):1180-3.

PMID:
8077310
32.

Treatment of hypophosphataemia.

Young IS, Neely RD, Lavery GG.

Lancet. 1993 Feb 6;341(8841):374. No abstract available.

PMID:
8094140
33.

Contribution of glucose/glucose 6-phosphate cycle activity to insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus.

Rooney DP, Neely RD, Beatty O, Bell NP, Sheridan B, Atkinson AB, Trimble ER, Bell PM.

Diabetologia. 1993 Feb;36(2):106-12.

PMID:
8458523
34.

Influence of growth hormone on glucose-glucose 6-phosphate cycle and insulin action in normal humans.

Neely RD, Rooney DP, Bell PM, Bell NP, Sheridan B, Atkinson AB, Trimble ER.

Am J Physiol. 1992 Nov;263(5 Pt 1):E980-7.

PMID:
1443131
35.

Insulin action and hepatic glucose cycling in essential hypertension.

Rooney DP, Neely RD, Ennis CN, Bell NP, Sheridan B, Atkinson AB, Trimble ER, Bell PM.

Metabolism. 1992 Mar;41(3):317-24.

PMID:
1542271
36.

The incidence of asymptomatic hypothyroidism in new referrals to a hospital lipid clinic.

O'Kane MJ, Neely RD, Trimble ER, Nicholls DP.

Ann Clin Biochem. 1991 Sep;28 ( Pt 5):509-11. No abstract available.

PMID:
1958056
37.
38.

Underestimation of glucose turnover determined using [6-3H]glucose tracer in non-steady state. The role of a tritiated tracer impurity.

Neely RD, Rooney DP, Atkinson AB, Sheridan B, Ennis CN, Trimble ER, Bell PM.

Diabetologia. 1990 Nov;33(11):681-7.

PMID:
2076800
39.

Tetany in association with gentamicin therapy.

Beatty OL, Campbell NP, Neely RD.

Ulster Med J. 1989 Apr;58(1):108-10. No abstract available.

40.
41.

Empyema necessitatis presenting as a swelling in the right hypochondrium.

Lawson JT, Bell PM, Neely RD, Porter KG.

Ulster Med J. 1987 Oct;56(2):140-2. No abstract available.

Supplemental Content

Loading ...
Support Center